E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast CancerYutaka Natori(Fukushima Medical University), Shigehira Saji(Fukushima Medical University)CancersJanuary 16, 202310.3390/cancers15020539Cited by 8SaveCiteExport RISWatch citationsRelated PapersNeoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial|The Lancet|2020|1.1kBreast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study|BMC Cancer|2017|64